These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38873158)
1. Engineered probiotic cocktail with two cascade metabolic Geng F; Wu M; Yang P; Li X; Pan X; Wang Y; Lü J Front Microbiol; 2024; 15():1366017. PubMed ID: 38873158 [TBL] [Abstract][Full Text] [Related]
2. The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase. Guo Y; Wu J; Wang M; Wang X; Jian Y; Yang C; Guo W J Neurosci; 2022 Mar; 42(13):2631-2646. PubMed ID: 35135854 [TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical, molecular and therapeutic aspects of 2 new cases of 2-aminoadipic semialdehyde synthase deficiency. Tondo M; Calpena E; Arriola G; Sanz P; Martorell L; Ormazabal A; Castejon E; Palacin M; Ugarte M; Espinos C; Perez B; Perez-Dueñas B; Pérez-Cerda C; Artuch R Mol Genet Metab; 2013 Nov; 110(3):231-6. PubMed ID: 23890588 [TBL] [Abstract][Full Text] [Related]
8. Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on terminology. Dancis J; Hutzler J; Cox RP Am J Hum Genet; 1979 May; 31(3):290-9. PubMed ID: 463877 [TBL] [Abstract][Full Text] [Related]
9. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1. Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766 [TBL] [Abstract][Full Text] [Related]
10. A case of hyperlysinemia identified by urine newborn screening. Yeganeh M; Auray-Blais C; Maranda B; Sabovic A; DeVita RJ; Lazarus MB; Houten SM JIMD Rep; 2023 Nov; 64(6):440-445. PubMed ID: 37927488 [TBL] [Abstract][Full Text] [Related]
11. An engineered Escherichia coli Nissle 1917 increase the production of indole lactic acid in the gut. Dimopoulou C; Bongers M; Pedersen M; Bahl MI; Sommer MOA; Laursen MF; Licht TR FEMS Microbiol Lett; 2023 Jan; 370():. PubMed ID: 37028942 [TBL] [Abstract][Full Text] [Related]
12. Enhancing the antibacterial function of probiotic Bartram E; Asai M; Gabant P; Wigneshweraraj S Appl Environ Microbiol; 2023 Nov; 89(11):e0097523. PubMed ID: 37930328 [TBL] [Abstract][Full Text] [Related]
13. Bacteriophage Cocktail and Microcin-Producing Probiotic Porter SB; Johnston BD; Kisiela D; Clabots C; Sokurenko EV; Johnson JR Front Microbiol; 2022; 13():887799. PubMed ID: 35547133 [TBL] [Abstract][Full Text] [Related]
14. Lysine biosynthesis in selected pathogenic fungi: characterization of lysine auxotrophs and the cloned LYS1 gene of Candida albicans. Garrad RC; Bhattacharjee JK J Bacteriol; 1992 Nov; 174(22):7379-84. PubMed ID: 1429460 [TBL] [Abstract][Full Text] [Related]
15. Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis. Yan X; Liu XY; Zhang D; Zhang YD; Li ZH; Liu X; Wu F; Chen GQ Cell Mol Immunol; 2021 Oct; 18(10):2344-2357. PubMed ID: 34480146 [TBL] [Abstract][Full Text] [Related]
16. Efficient biosynthesis of α-aminoadipic acid via lysine catabolism in Escherichia coli. Zhang Y; An N; Zhao Y; Li X; Shen X; Wang J; Sun X; Yuan Q Biotechnol Bioeng; 2023 Jan; 120(1):312-317. PubMed ID: 36226358 [TBL] [Abstract][Full Text] [Related]
17. Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice. Tang H; Zhou T; Jin W; Zong S; Mamtimin T; Salama ES; Jeon BH; Liu P; Han H; Li X Life Sci; 2023 Jul; 324():121709. PubMed ID: 37100380 [TBL] [Abstract][Full Text] [Related]
18. Dual engineered bacteria improve inflammatory bowel disease in mice. Wu YQ; Zou ZP; Zhou Y; Ye BC Appl Microbiol Biotechnol; 2024 May; 108(1):333. PubMed ID: 38739270 [TBL] [Abstract][Full Text] [Related]
19. Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5-aminolevulinic acid. Chen J; Li X; Liu Y; Su T; Lin C; Shao L; Li L; Li W; Niu G; Yu J; Liu L; Li M; Yu X; Wang Q Microb Biotechnol; 2021 Sep; 14(5):2130-2139. PubMed ID: 34272828 [TBL] [Abstract][Full Text] [Related]
20. Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic Kim D; Kim Y; Yoon SH Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672760 [No Abstract] [Full Text] [Related] [Next] [New Search]